Letter to the Editor

Abstract

References

Wong JM , Esdaile JM. Methotrexate in systemic lupus erythematosus . Lupus 2005; 14: 101-105 .

Wenzel J , Brähler S , Bauer R et al. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients . Br J Dermatol 2005; 153-153 (in press).

Wenzel J , Hense S , Brähler S et al. The expression of HLA-DR and CD25 on circulating T cells in cutaneous lupus erythematosus and correlation with disease activity . Exp Dermatol 2005; 14: 454-459 .

Wenzel J , Bieber T , Uerlich M et al. Systemic treatment of cutaneous lupus erythematosus . JDDG 2003; 1: 694-704 .

Kuhn A , Specker C , Ruzicka T et al. Methotrexate treatment for refractory subacute cutaneous lupus erythematosus . J Am Acad Dermatol 2002; 46: 600-603 .

Boehm I , Wenzel J. FACS monitoring of lymphocyte-subsets in patients with discoid and subacute-cutaneous lupus erythematosus receiving low-dose methotrexate . Scand J Rheumatol 2002; 31: 216-220 .

Bohm L , Uerlich M , Bauer R. Rapid improvement of subacute cutaneous lupus erythematosus with low-dose methotrexate . Dermatology 1997; 194: 307-308 .

Jessop S , Whitelaw D , Jordaan F. Drugs for discoid lupus erythematosus . Cochrane Database Syst Rev 2001; CD002954-CD002954 .

Cronstein BN. The mechanism of action of methotrexate . Rheum Dis Clin North Am 1997; 23: 739-755 .

10.

Sigmundsdottir H , Johnston A , Gudjonsson JE et al. Methotrexate markedly reduces the expression of vascular E-selectin, cutaneous lymphocyte-associated antigen and the numbers of mononuclear leucocytes in psoriatic skin . Exp Dermatol 2004; 13: 426-434 .

11.

Johnston A , Gudjonsson JE , Sigmundsdottir H et al. The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules . Clin Immunol 2005; 114: 154-163 .